CONTACT
|
PROVIDER PORTAL
|
PROVIDER SEARCH
|
REIMBURSEMENT
INDICATIONS
Musculoskeletal
SoftWave Wound Care
Wound Case Study
ABOUT
SoftWave Technology
OrthoGold 100®
UroGold100
DermaGold 100®
Shockwave Therapy
ABOUT US
BOARD
Privacy Policy
News & Press Releases
FDA Clearances
Softwave Blog
FAQs
Events
RESEARCH
Pain/Sports Med/Regenerative Research Library
Urology Research Library
Podiatry Research Library
Wound/Burn Research Library
PATIENTS
BECOME A PROVIDER
DISTRIBUTORS
CONTACT US
Contact Us
PROVIDERS SEARCH
CONTACT
|
PROVIDER PORTAL
|
PROVIDER SEARCH
|
REIMBURSEMENT
INDICATIONS
Musculoskeletal
SoftWave Wound Care
Wound Case Study
ABOUT
SoftWave Technology
OrthoGold 100®
UroGold100
DermaGold 100®
Shockwave Therapy
ABOUT US
BOARD
Privacy Policy
News & Press Releases
FDA Clearances
Softwave Blog
FAQs
Events
RESEARCH
Pain/Sports Med/Regenerative Research Library
Urology Research Library
Podiatry Research Library
Wound/Burn Research Library
PATIENTS
BECOME A PROVIDER
DISTRIBUTORS
CONTACT US
Contact Us
PROVIDERS SEARCH
Home
Protocols
Service/Troubleshooting
Marketing
Clinical Docs
FAQ
Products/Refurb
Cart
Contact Us
Logout
The influence of comorbidities and etiologies on the success of extracorporeal shock wave therapy for chronic soft tissue wounds: midterm results.
SoftWave Literature
Wolff et al.
Ultrasound Med Biol. 2011 Jul;37(7):1111-9.
Click here to read more.
0
Shares
Prev
Next
Related Posts
Alternatives to Surgery
Blog
,
Uncategorized
Alternatives to Cortisone Shots
Blog
Using Sound to Battle Opioid Crisis
Blog
